References
- Riou J., Godart C., Hurtrel D., Mathis M., Bimet C., Bardakdjian‐Michau J., Préhu C., Wajcman H., Galactéros F. Evaluation of cation‐exchange high‐performance liquid‐chromatography for presumptive identification of hemoglobin variants. J. Clin. Chem. 1997; 43: 34–39
- Hocking D. R. The Separation and Identification of Hemoglobin Variants by Isoelectric Focusing Electrophoresis: an Interpretive Guide, T. H. J. Huisman. Isolab Inc., Akron, OHUSA 1997
- Schneider R. G., Barwick R. C. Electrophoretic mobilities of mutant hemoglobins and mutant globin chains. CRC Handbook Series in Clinical Laboratory Science, Section I: Hematology, R. M. Schmidt, V. F. Fairbanks. CRC Press, Boca Raton, FLUSA 1986; Vol. IV: 125–139, Vol. I
- Wajcman H., Bardakdjian J., Ducrocq R. Structural characterization of abnormal hemoglobins from dried blood specimens in a neonatal screening program. Ann. Biol. Clin. 1993; 50: 867–870
- Deon C., Promé J. C., Promé D., Francina A., Groff P., Kalmes G., Galactéros F., Wajcman H. Combining mass spectrometry methods allows characterization of human hemoglobin variants localized within αT9 peptide: identification of Hb Villeurbanne α89 (FG1) His→Tyr. J. Mass Spectrom. 1997; 32: 880–887
- Huisman T. H. J. Separation of hemoglobins and hemoglobin chains by high performance liquid chromatography. J. Chromatogr. 1987; 418: 277–304
- Schneider R. G., Alperin J. B., Brimhall B., Jones R. T. Hemoglobin P (α2 β2117 Arg): structure and properties. J. Lab. Clin. Med. 1969; 73: 616–622
- Ohba Y., Hasegawa Y., Amino H., Miwa S., Nakatsuji T., Hattori Y., Miyaji T. Hemoglobin Saitama or β117 (G19) His→Pro, a new variant causing hemolytic disease. Hemoglobin 1983; 7: 47–56